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The  efﬁcacy  of  eprinomectin  in  an  extended-release  injection  (ERI)  formulation  in the  treat-
ment of  cattle  harboring  naturally  acquired  nematode  populations  (including  inhibited
nematodes)  was  evaluated.  Five  studies  were  conducted  under  a similar  protocol  in the  USA,
the UK,  and  in Germany.  All  study  animals  were  infected  by  grazing  naturally  contaminated
pastures.  The  adequacy  of pasture  infectivity  was  conﬁrmed  by  examining  tracer  calves
prior  to  allocation  and  treatment  of  the  study  animals.  The  cattle  were  of various  breeds  or
crosses, weighing  79–491  kg, and  aged  approximately  6–15 months.  In  each  study,  20 ani-
mals were  infected  by  grazing,  and  then  removed  from  pasture  and  housed  in  a manner  to
preclude further  nematode  infections  for  8–16 days  until  treatment.  Animals  were  blocked
based on  descending  pre-treatment  body  weight  and  randomly  allocated  to  one  of  two
treatments:  ERI  vehicle  (control)  at 1 mL/50  kg  body  weight  or eprinomectin  5%  (w/v)  ERI at
1 mL/50  kg  body  weight  (1.0 mg  eprinomectin/kg).  Treatments  were  administered  once  on
Day 0  by  subcutaneous  injection  in  front of the  shoulder.  For  parasite  recovery  and  count,
all study  animals  were  humanely  euthanized  14/15  days  after  treatment.  Cattle  treated
with eprinomectin  ERI  had signiﬁcantly  (p < 0.05)  fewer  of the  following  nematodes  than
the controls  with  overall  reduction  of parasite  counts  of  ≥94%:  adult  Dictyocaulus  viviparus,
Capillaria  spp.,  Cooperia  oncophora,  Cooperia  pectinata,  Cooperia  punctata,  Cooperia  surn-
abada, Haemonchus  placei,  Nematodirus  helvetianus,  Oesophagostomum  radiatum,  Ostertagia
lyrata,  Ostertagia  ostertagi,  Trichostrongylus  axei,  Trichostrongylus  colubriformis,  Trichuris  dis-
color, Trichuris  skrjabini,  and  Trichuris  spp.;  developing  fourth-stage  larvae  of Ostertagia  spp.
and Trichostrongylus  spp.;  and inhibited  fourth-stage  larvae  of  Cooperia  spp.,  Haemonchus
spp.,  Nematodirus  spp., Oesophagostomum  spp.,  Ostertagia  spp.,  and  Trichostrongylus  spp.Animal  treatments  were  well  accepted,  with  no  adverse  reactions  to treatment  observed
in any  study  animals.  The  results  of  this  series  of  controlled  studies  demonstrated  high
therapeutic  efﬁcacy  and  acceptability  of  eprinomectin  ERI  against  pulmonary  nematodes
and  a wide  range  of gastrointestinal  parasitic  infections,  including  inhibited  gastrointestinal
le.
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1. Introduction
Open access under CC BY-NC-ND license.Eprinomectin, a recently commercialized member of
the  macrocyclic lactone class of parasiticides has been
proven highly effective as a pour-on formulation for
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cattle in the prevention and control of a wide range of endo-
and ectoparasites in cattle (e.g., Barth et al., 1997; Shoop
et al., 1996; Gogolewski et al., 1997a,b; Holste et al., 1997,
1998; Pitt et al., 1997; Williams et al., 1997; Yazwinski et al.,
1997; Cramer et al., 2000; Campbell et al., 2001; Davey and
George, 2002; Shoop and Soll, 2002; Rehbein et al., 2005).
While highly effective as a pour-on formulation in pro-
viding persistent therapeutic control, prophylactic success
also has been demonstrated against important nematode
species (e.g., Batty et al., 1999; Epe et al., 1999; Dorny et al.,
2000).
In a concerted effort to further lengthen the persis-
tent activity of eprinomectin an extended-release injection
(ERI) formulation has been developed for cattle which
releases the active material in an efﬁcacious manner for
up to 150 days (Soll et al., 2013). This new formulation
provides ﬂexibility for strategic protection and control of
endo- and ectoparasites.
The studies reported here were designed to con-
ﬁrm the efﬁcacy and acceptability of eprinomectin ERI
when administered to cattle harboring naturally acquired
gastrointestinal and pulmonary nematode infections,
including inhibited nematodes. Inhibition of development
in the immature stage is a characteristic feature in the life-
cycle of ruminant trichostrongyloid nematodes, occurring
in Cooperia, Haemonchus, Trichostrongylus, Nematodirus,
and Ostertagia species.  However, inhibition is of special
epidemiological and pathogenic relevance in Ostertagia
ostertagi, the most economically important gastrointesti-
nal nematode in cattle. The larval inhibition appears to
be induced by environmental stimuli – climatic condi-
tions less favorable for development and/or survival of
free-living larval stages (fall of temperatures in autumn in
northern temperate regions or dry and hot conditions in
southern temperate climates) – but might also be affected
by the development of both acquired immunity and age
resistance. The duration of arrested development has been
documented to last from a few weeks up to several months,
so potentially large numbers of larvae can accumulate
(Bürger, 1992; Taylor et al., 2007).
2. Materials and methods
Five controlled studies were conducted according to
a similar protocol, three in the USA, one in the UK, and
one in Germany. Cattle harboring naturally acquired nema-
tode infections were utilized. The studies were designed
and conducted to comply with the regulatory require-
ments of both the FDA/CVM and the European Medicines
Agency/Committee for Medicinal Products for Veterinary
Use, and according to relevant guidelines for Good Clinical
Practices (GCPs) and for establishing the efﬁcacy of cattle
anthelmintics.
All ﬁve studies were performed in a blinded fashion, and
personnel involved with data collection were unaware of
the treatment group assignments.2.1. Experimental animals
A total of 100 (42 male, 35 male castrate, 23 female)
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Holstein, Holstein Friesian, and Friesian cattle, weighing
79–491 kg prior to treatment (Days −1 or 0), and aged
approximately 6–15 months at the time of treatment were
used. The ﬁve studies were conducted in the USA (Study
#2 in Arkansas during June, #4 in Louisiana during May,
and #5 in Missouri during September to December), in
Germany (Study #3 in Upper Bavaria during December),
and in the UK (Study #1 in Scotland during November to
December). The animal descriptions and details are pre-
sented in Table 1. None of the animals had been previously
treated with an avermectin or milbemycin product.
Cattle for all ﬁve studies were grazed on naturally con-
taminated pastures prior to treatment and were expected
to be harboring naturally acquired nematode infections. To
conﬁrm pasture infectivity and to demonstrate the pres-
ence of adequate nematode infections (including inhibited
fourth-stage larvae), a total of 16 tracer animals (at least
two animals per study site) were commingled with the
study animals. They were removed from pasture, housed to
preclude further nematode infection, and were necropsied
8–16 days later for parasite identiﬁcation and enumeration.
Examination of tracer calves was  completed prior to Day 0
for animals enrolled in the efﬁcacy studies.
2.2. Study design
Each of the studies was  conducted utilizing a random-
ized block design. Ten replicates of two animals each
were formed based on descending Day −1 or Day 0 body
weights. Within replicates, one animal was  randomly allo-
cated to each treatment group. Group 1 animals received
the ERI vehicle (control) at 1 mL/50 kg bodyweight sub-
cutaneously once on Day 0. Group 2 animals received
eprinomectin 5% (w/v) ERI solution at a targeted dosage
of 1.0 mg  eprinomectin/kg bodyweight (1 mL/50 kg) sub-
cutaneously once on Day 0. The appropriate dose volume
for each animal was administered in front of the right or
left shoulder using commercial syringes and needles. Dose
volumes were based on pre-treatment body weights and
measured at 0.1 mL  increments. Calculated doses that fell
between increments were rounded up to the next greater
0.1 mL.
2.3. Parasite counts
All study animals were humanely euthanized and
necropsied for nematode counting and identiﬁcation 14/15
days after treatment (22–31 days after removal from pas-
ture). The following organs were removed for content
recovery and examination: heart–lung complex (Studies
4 and 5), lungs with trachea (Studies 2 and 3), abo-
masa, small intestines and large intestines (including the
cecum, all studies). Total lungworms were collected and
counted. The contents of the abomasa, small intestines
and large intestines were collected separately and diluted
with water. The abomasum and small intestine of each calf
were incubated separately (saline soak) to recover mucosal
stages of the parasites for counting and identiﬁcation. For
all animals within each study, the entire contents or a
known percentage of the contents of each organ (aboma-
sum and small intestine contents: 2.5%, 5%, 10% or 20%
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Table 1
Animal description and details.
Studya Treatmentb/animals
per treatment
Breed Sex ∼Age
(months)
Pre-treatment
body weight (kg)
1 Control
EpERI
n = 10
n = 10
Holstein-Friesian,
Friesian, Friesian
cross
Male 11–15 195–315
2 Control
EpERI
n  = 10
n = 10
Holstein Male castrate 6 79–182
3  Control
EpERI
n = 10
n = 10
Holstein-Friesian Male 12 353–491
4  Control
EpERI
n = 10
n = 10
Crossbred beef 2 male, 3 male castrate, 15
female
9–14 137–224
5  Control
EpERI
n = 10
n = 10
Angus cross 12 male castrate, 8 female 9–15 142–239
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Sa Study sites: Study 1 = Scotland, UK; Study 2 = Arkansas, USA; Study 3 =
b Control = ERI vehicle; EpERI = eprinomectin ERI.
liquots; abomasum and small intestine soaks 2%, 2.5%,
%, or 10% aliquots; large intestine content: 5%, 10%, 20%
liquots or total count) were examined. Preliminary counts
ere multiplied by the inverse of the aliquot percentage to
alculate ﬁnal worm counts.
Counts of individual parasite species were calculated
y multiplying the numbers of worms recovered from
ach organ by the inverse of the aliquot percentage. Ani-
al  and treatment group worm counts were calculated,
nd summed over all locations for each parasite species.
ematodes were identiﬁed to genus or species and stage
f development (where possible) according to recognized
ethods and procedures. Adult female nematodes and/or
ourth-stage larvae (L4s) were not always identiﬁed to
pecies level. For several nematode genera (i.e., Cooperia,
stertagia, and Trichostrongylus), the total species counts
ere estimated by proportionally assigning adult females
o each species based on the adult male counts. When
dult females within genera were counted in the presence
f no males, the counts were either proportioned equally
r assigned based on the species present in other study
nimals. For Trichostrongylus spp., in some studies, non-
peciated nematodes were assigned to species based on the
ocation in which the nematodes were found.
.4. Statistical methods
Nematode counts were transformed to the natural log-
rithm (count + 1) for analysis and calculation of geometric
eans. Treatment groups were compared using a Wilcoxon
ank sum test. A two-sided test was used at  ˛ = 0.05. Efﬁcacy
as calculated as 100[(C − T)/C], where C is the geometric
ean for the ERI vehicle-treated (control) group and T is the
eometric mean for the eprinomectin ERI-treated group.
. Results
Nematode counts in the tracer animals at all study
ites supported the presence of a sufﬁcient number
>1000) of inhibited L4s of Ostertagia spp. and thus
esulted in the enrollment of the cattle of all sites into
tudies. In addition, identiﬁcation of adult gastrointesti-
al nematodes recovered from the tracer animals at
tudy sites 2 (Arkansas/USA), 3 (Upper Bavaria/Germany)Bavaria, Germany; Study 4 = Louisiana, USA; Study 5 = Missouri, USA.
4  (Louisiana/USA), and 5 (Missouri/USA) revealed the
presence of nematodes of the following genera: Capil-
laria (Study 2), Cooperia (Studies 2–5), Dictyocaulus (Study
3), Haemonchus (Study 5), Nematodirus (Studies 2 and 3),
Oesophagostomum (Studies 2–5), Ostertagia (Studies 2–5),
Trichostrongylus (Studies 4 and 5), and/or Trichuris (Studies
2–4).
In all ﬁve studies, treatment was  well accepted and cat-
tle were reported as normal during hourly observations
through the ﬁrst four hours post-treatment. There were no
drug related health problems or adverse events related to
the drug at any time during the studies. Prior to treatment,
some animals exhibited clinical signs of parasitic disease
but none required salvage treatment.
In total, 20 species of nematodes – 15 species in the
cattle from the two  study sites in Europe and 17 species
in the cattle from the three study sites in the USA – were
recorded in the gastrointestinal tracts and lungs of control
animals in this set of studies. These species comprise all
of the economically relevant nematode parasites of graz-
ing cattle. The majority of these species occurred in high
enough numbers and in a sufﬁcient proportion of control
animals for meaningful analyses to be performed.
At necropsy, 22–31 days after removal from pasture
and 14/15 days after treatment, the groups that received
eprinomectin ERI had signiﬁcantly (p < 0.05) fewer of the
following nematodes than the ERI vehicle-treated (con-
trol) cattle with overall reduction of nematode counts
by ≥94% (Table 2): Dictyocaulus viviparus, Capillaria spp.,
Cooperia oncophora,  Cooperia pectinata, Cooperia punctata,
Cooperia surnabada,  Haemonchus placei,  Nematodirus hel-
vetianus, Oesophagostomum radiatum, Ostertagia lyrata, O.
ostertagi, Ostertagia spp. developing fourth-stage larvae,
Trichostrongylus axei, Trichostrongylus colubriformis, Tri-
chostrongylus spp. developing fourth-stage larvae, Trichuris
discolor, Trichuris skrjabini, and immature and adult
Trichuris spp.
Additionally, cattle treated with eprinomectin ERI had
signiﬁcantly (p < 0.05) fewer inhibited fourth-stage larvae
of the following nematode genera than the ERI vehicle-
treated (control) cattle with overall reduction of counts
by ≥94% (Table 3): Cooperia spp., Haemonchus spp., Nema-
todirus spp., Oesophagostomum spp., Ostertagia spp., and
Trichostrongylus spp. While the efﬁcacy of eprinomectin ERI
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Table  2
Therapeutic efﬁcacy of eprinomectin ERI against adult and developing pulmonary and gastrointestinal nematodes.
Study #a Control (vehicle) Eprinomectin ERI Efﬁcacyd Probabilitye
Prevalenceb GMc Prevalence GM
Dictyocaulus viviparus
3  9/10 30 0/10 0 100% <0.01
4  10/10 24 0/10 0 100% <0.05
Cooperia oncophora
1 10/10 1476 7/10 68 95% <0.05
2 10/10 7686 9/10 208 97% <0.05
3 10/10 809 5/10 4 >99% <0.01
Cooperia pectinata
4  9/10 800 0/10 0 100% <0.05
Cooperia punctata
2  10/10 558 3/10 2 >99% <0.05
3  8/10 18 1/10 <1 98% <0.01
4  10/10 4222 0/10 0 100% <0.05
5 9/10 337 1/10 <1 >99% <0.05
Cooperia surnabada
1 7/10 79 3/10 4 95% <0.05
2  10/10 534 8/10 28 95% <0.05
3  4/10 14 1/10 <1 95% nsf
Haemonchus placei
2  10/10 653 1/10 <1 >99% <0.05
4 4/10 13 0/10 0 100% <0.05
5  5/10 12 1/10 <1 96% nsf
Nematodirus helvetianus
2  10/10 44 0/10 0 100% <0.05
Oesophagostomum radiatum
1 4/10 1 0/10 0 100% <0.05
2  6/10 8 0/10 0 100% <0.05
3 10/10 7 0/10 0 100% <0.01
4  10/10 185 0/10 0 100% <0.05
5 10/10 101 0/10 0 100% <0.05
Ostertagia lyrata
2 10/10 139 2/10 <1 >99% <0.05
3  6/10 7 0/10 0 100% <0.01
4  4/10 8 0/10 0 100% <0.05
5 9/10 702 0/10 0 100% <0.05
Ostertagia ostertagi
1 10/10 7030 2/10 1 >99% <0.01
2  10/10 4747 5/10 2 >99% <0.05
3  10/10 1651 0/10 0 100% <0.01
4 10/10 9236 1/10 <1 >99% <0.05
5  10/10 30158 2/10 <1 >99% <0.05
Ostertagia spp., developing (late) fourth-stage larvae
1  10/10 327 1/10 <1 >99% <0.01
2  10/10 113 0/10 0 100% <0.05
4  8/10 211 5/10 13 94% <0.05
5  10/10 1751 3/10 2 >99% <0.05
Trichostrongylus axei
1  8/10 141 0/10 0 100% <0.01
2  5/10 3 0/10 0 100% <0.05
3  10/10 224 0/10 0 100% <0.01
4  10/10 3931 0/10 0 100% <0.05
5  10/10 53640 2/10 1 >99% <0.05
Trichostrongylus colubriformis
1  8/10 163 0/10 0 100% <0.01
2  5/10 3 0/10 0 100% <0.05
Trichostrongylus spp., developing (late) fourth-stage larvae
1  10/10 247 0/10 0 100% <0.01
Trichuris discolor
3  9/10 11 0/10 0 100% <0.01
Trichuris skrjabini
3  5/10 1 0/10 0 100% <0.05
Trichuris spp.
1  8/10 8 0/10 0 100% <0.01
2  9/10 21 1/10 <1 98% <0.05
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Table 2 (Continued)
Study #a Control (vehicle) Eprinomectin ERI Efﬁcacyd Probabilitye
Prevalenceb GMc Prevalence GM
Trichuris spp., immature
2 9/10 8 2/10 <1 94% <0.05
a Study sites: Study 1 = Scotland, UK; Study 2 = Arkansas, USA; Study 3 = Upper Bavaria, Germany; Study 4 = Louisiana, USA; Study 5 = Missouri, USA.
b Prevalence: number of cattle infected/Number of cattle in group.
c Geometric mean counts (based on transformation to the natural logarithm of [count + 1]).
d Efﬁcacy = 100 [(geometric mean control −geometric mean eprinomectin ERI)/geometric mean control].
e Probability from Wilcoxon rank sum test.
f Not signiﬁcant at  ˛ = 0.05.
Table 3
Therapeutic efﬁcacy of eprinomectin ERI against inhibited gastrointestinal nematodes.
Studya ERI vehicle (control) Eprinomectin ERI Efﬁcacyd Probabilitye
Prevalenceb GMc Prevalence GM
Cooperia spp.
1 9/10 1002 2/10 2 >99% <0.01
2  10/10 34 0/10 0 100% <0.05
4  8/10 155 1/10 <1 >99% <0.05
5 3/10 2 0/10 0 –f nag
Haemonchus spp.
2 6/10 6 0/10 0 100% <0.05
4  3/10 4 0/10 0 – na
5  6/10 10 0/10 0 100% <0.05
Nematodirus spp.
1 7/10 160 0/10 0 100% <0.01
2  8/10 13 0/10 0 100% <0.05
Oesophagostomum spp.
1 2/10 <1 0/10 0 – na
2  1/10 <1 0/10 0 – na
5  4/10 1 0/10 0 100% <0.05
Ostertagia spp.
1 10/10 201124 10/10 1422 99% <0.01
2 10/10  2182 5/10 <1 >99% <0.05
3  10/10 10803 10/10 908 92% <0.01
4  10/10 30773 10/10 5726 81% <0.05
5  10/10 5666 5/10 10 >99% <0.05
Trichostrongylus spp.
1 1/10 <1h 0/10 0 – na
1  10/10 4842i 1/10 <1 >99% <0.01
5  4/10 5 1/10 <1 93% nsj
a Study sites: Study 1 = Scotland, UK; Study 2 = Arkansas, USA; Study 3 = Upper Bavaria, Germany Study 4 = Louisiana, USA; Study 5 = Missouri, USA.
b Prevalence: number of cattle infected/Number of cattle in group.
c Geometric mean counts (based on transformation to the natural logarithm [count + 1]).
d Efﬁcacy = 100 [(geometric mean control − geometric mean eprinomectin ERI)/geometric mean control].
e Probability from Wilcoxon rank sum test.
f Not calculated due to a prevalence of <40% in the control group.
g
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fNot analyzed.
h Abomasum.
i Small intestine.
j Not signiﬁcant at  ˛ = 0.05.
gainst inhibited L4s of Ostertagia spp. was 92% to >99% in
our studies, reduction of inhibited Ostertagia spp. larvae
as 81% in the study conducted in Louisiana. In the analy-
is of pooled data across the ﬁve studies for inhibited L4s of
stertagia spp. overall efﬁcacy was calculated to be 94.4%
overall efﬁcacy was calculated as the arithmetic mean of
ndividual study efﬁcacies; p < 0.05, Friedman’s test).
. DiscussionPrior to removal from pasture, cattle in each of the ﬁve
tudies were subjected to prolonged nematode exposure
n naturally contaminated pastures. Nematode recoveries
rom tracer cattle as well as controls supported thepresence of a sufﬁcient number of inhibited Ostertagia spp.
larvae in addition to a range of adult nematodes of several
genera. The species identiﬁed were well representative
of those known to cause parasitic gastroenteritis and
bronchitis in North America and Europe.
Based on parasite recoveries of the cattle carrying nat-
urally acquired nematode infections, the current series
of studies conducted at different geographical locations
in the USA and in Europe consistently demonstrated a
high level of therapeutic effectiveness of eprinomectin ERI
(≥94%) against pulmonary nematodes and a wide range of
bovine gastrointestinal parasites. This conﬁrms results of
controlled studies, conducted to assess the therapeutic efﬁ-
cacy of eprinomectin ERI against experimentally induced
ry ParasJ.S. Hunter III. et al. / Veterina
adult and developing nematode infections (Rehbein et al.,
2013a,b) and ﬁeld studies where efﬁcacy was demon-
strated by ≥96% reduction of fecal egg or larval counts
of eprinomectin ERI-treated cattle compared to vehicle-
treated controls (Kunkle et al., 2013; Rehbein et al.,
2013a,b).
Approximately four weeks before necropsy, all study
animals were removed from infective pastures and held
under conditions to prevent further nematode infection.
This provided adequate time for nematodes with three-
to four-week prepatent periods to complete development
to the adult stage. Immature nematodes recovered at
necropsy in the L4 stage were therefore considered to be
inhibited (Williams et al., 1997; Taylor et al., 2007). The
overall therapeutic efﬁcacy of eprinomectin ERI against
inhibited Ostertagia spp. L4s was high, and thus consis-
tent with that of eprinomectin as a topical formulation
(Williams et al., 1997). However, compared to studies con-
ducted with topical eprinomectin (Williams et al., 1997),
some variability was seen between the results in the cur-
rent set of studies. This variability may  be related to the
length of the interval between treatment and slaughter
employed in the two sets of studies. The three-week inter-
val practiced by Williams et al. (1997) allowed extended
time for clearance of larvae from the abomasal tissue (pas-
sage of and/or disintegration and resolution) compared to
the two weeks used in the present studies.
Results of the current series of studies as well as
other similarly controlled studies in the USA and Europe
(Rehbein et al., 2013a,b) demonstrated the high effec-
tiveness of eprinomectin LAI in cattle against naturally
acquired and induced infections of adult, developing and
inhibited immature nematode stages. Additionally, pro-
phylactic efﬁcacy under natural challenge conditions was
demonstrated for at least 120 days using eprinomectin ERI,
which prevented the accumulation of inhibited larvae of
several nematode genera and stages, including the impor-
tant early fourth-stage larvae of Ostertagia spp. (Rehbein
et al., 2013a,b).
In conclusion, the results of these ﬁve controlled studies
in cattle demonstrated excellent therapeutic efﬁcacy and
acceptability of eprinomectin ERI against a wide range of
naturally acquired adult and inhibited gastrointestinal and
pulmonary nematodes, including O. ostertagi, after a single
treatment administered subcutaneously at 1 mL/50 kg.
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